-
1
-
-
0035224336
-
Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer
-
Horita K, Yamaguchi A, Hirose K, Ishida M, Noriki S, Imamura Y, Fukuda M, Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer, Eur J Histochem, 2001, 45(1):73-84.
-
(2001)
Eur J Histochem
, vol.45
, Issue.1
, pp. 73-84
-
-
Horita, K.1
Yamaguchi, A.2
Hirose, K.3
Ishida, M.4
Noriki, S.5
Imamura, Y.6
Fukuda, M.7
-
2
-
-
77957343443
-
Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype
-
Sahab ZJ, Man YG, Semaan SM, Newcomer RG, Byers SW, Sang QX, Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype, Clin Exp Metastasis, 2010, 27(7):493-503.
-
(2010)
Clin Exp Metastasis
, vol.27
, Issue.7
, pp. 493-503
-
-
Sahab, Z.J.1
Man, Y.G.2
Semaan, S.M.3
Newcomer, R.G.4
Byers, S.W.5
Sang, Q.X.6
-
3
-
-
12344308462
-
Estrogen receptor-negative breast carcinomas: A review of morphology and immunopheno-typical analysis
-
Putti TC, El-Rehim DM, Rakha EA, Paish CE, Lee AH, Pinder SE, Ellis IO, Estrogen receptor-negative breast carcinomas: a review of morphology and immunopheno-typical analysis, Mod Pathol, 2005, 18(1):26-35.
-
(2005)
Mod Pathol
, vol.18
, Issue.1
, pp. 26-35
-
-
Putti, T.C.1
El-Rehim, D.M.2
Rakha, E.A.3
Paish, C.E.4
Lee, A.H.5
Pinder, S.E.6
Ellis, I.O.7
-
4
-
-
0021723038
-
Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading
-
Parl FF, Schmidt BP, Dupont WD, Wagner RK, Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading, Cancer, 1984, 54(10):2237-2242.
-
(1984)
Cancer
, vol.54
, Issue.10
, pp. 2237-2242
-
-
Parl, F.F.1
Schmidt, B.P.2
Dupont, W.D.3
Wagner, R.K.4
-
5
-
-
11444251764
-
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
-
ATAC Trialists' Group
-
Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS; ATAC Trialists' Group, Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer, Lancet, 2005, 365(9453):60-62.
-
(2005)
Lancet
, vol.365
, Issue.9453
, pp. 60-62
-
-
Howell, A.1
Cuzick, J.2
Baum, M.3
Buzdar, A.4
Dowsett, M.5
Forbes, J.F.6
Hoctin-Boes, G.7
Houghton, J.8
Locker, G.Y.9
Tobias, J.S.10
-
6
-
-
0019391670
-
The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast
-
Paone JF, Abeloff MD, Ettinger DS, Arnold EA, Baker RR, The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast, Surg Gynecol Obstet, 1981, 152(1):70-74.
-
(1981)
Surg Gynecol Obstet
, vol.152
, Issue.1
, pp. 70-74
-
-
Paone, J.F.1
Abeloff, M.D.2
Ettinger, D.S.3
Arnold, E.A.4
Baker, R.R.5
-
7
-
-
0024337144
-
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
-
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A et al., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science, 1989, 244(4905):707-712.
-
(1989)
Science
, vol.244
, Issue.4905
, pp. 707-712
-
-
Slamon, D.J.1
Godolphin, W.2
Jones, L.A.3
Holt, J.A.4
Wong, S.G.5
Keith, D.E.6
Levin, W.J.7
Stuart, S.G.8
Udove, J.9
Ullrich, A.10
-
8
-
-
14944378076
-
Expression levels and clinical-pathological correlations of HER2/neu in primary and metastatic human breast cancer
-
Stefano R, Agostara B, Calabrò M, Campisi I, Ravazzolo B, Traina A, Miele M, Castagnetta L, Expression levels and clinical-pathological correlations of HER2/neu in primary and metastatic human breast cancer, Ann N Y Acad Sci, 2004, 1028:463-472.
-
(2004)
Ann N Y Acad Sci
, vol.1028
, pp. 463-472
-
-
Stefano, R.1
Agostara, B.2
Calabrò, M.3
Campisi, I.4
Ravazzolo, B.5
Traina, A.6
Miele, M.7
Castagnetta, L.8
-
9
-
-
0036151588
-
Use of the American College of Radiology BI-RADS to report on the mammographic evaluation of women with signs and symptoms of breast disease
-
Geller BM, Barlow WE, Ballard-Barbash R, Ernster VL, Yankaskas BC, Sickles EA, Carney PA, Dignan MB, Rosenberg RD, Urban N, Zheng Y, Taplin SH, Use of the American College of Radiology BI-RADS to report on the mammographic evaluation of women with signs and symptoms of breast disease, Radiology, 2002, 222(2):536-542.
-
(2002)
Radiology
, vol.222
, Issue.2
, pp. 536-542
-
-
Geller, B.M.1
Barlow, W.E.2
Ballard-Barbash, R.3
Ernster, V.L.4
Yankaskas, B.C.5
Sickles, E.A.6
Carney, P.A.7
Dignan, M.B.8
Rosenberg, R.D.9
Urban, N.10
Zheng, Y.11
Taplin, S.H.12
-
10
-
-
0003783933
-
-
rd edition, American College of Radiology, Reston, VA
-
rd edition, American College of Radiology, Reston, VA, 1998.
-
(1998)
Illustrated Breast Imaging Reporting and Data System: Illustrated BI-RADS
-
-
D'Orsi, C.J.1
Bassett, L.W.2
Feig, S.A.3
-
11
-
-
0026072872
-
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer:Experience from a large study with long-term follow-up
-
Elston CW, Ellis IO, Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer:experience from a large study with long-term follow-up, Histopathology, 1991, 19(5):403-410.
-
(1991)
Histopathology
, vol.19
, Issue.5
, pp. 403-410
-
-
Elston, C.W.1
Ellis, I.O.2
-
12
-
-
45949095697
-
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: Impact on selecting patients for herceptin therapy
-
Brunelli M, Manfrin E, Martignoni G, Bersani S, Remo A, Reghellin D, Chilosi M, Bonetti F, HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy, Am J Clin Pathol, 2008, 129(6):907-911.
-
(2008)
Am J Clin Pathol
, vol.129
, Issue.6
, pp. 907-911
-
-
Brunelli, M.1
Manfrin, E.2
Martignoni, G.3
Bersani, S.4
Remo, A.5
Reghellin, D.6
Chilosi, M.7
Bonetti, F.8
-
13
-
-
19344364880
-
Effect of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomized trials
-
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
-
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Effect of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials, Lancet, 2005, 365(9472):1687-1717.
-
(2005)
Lancet
, vol.365
, Issue.9472
, pp. 1687-1717
-
-
-
14
-
-
1342310251
-
The sequencing of radiation therapy and chemotherapy after mastectomy in premenopausal women with breast cancer
-
Cakir S, Gursel B, Meydan D, Yildiz L, The sequencing of radiation therapy and chemotherapy after mastectomy in premenopausal women with breast cancer, Jpn J Clin Oncol, 2003, 33(11):563-569.
-
(2003)
Jpn J Clin Oncol
, vol.33
, Issue.11
, pp. 563-569
-
-
Cakir, S.1
Gursel, B.2
Meydan, D.3
Yildiz, L.4
-
15
-
-
38749117179
-
Prognostic effect of estrogen receptor status across age in primary breast cancer
-
Bentzon N, Düring M, Rasmussen BB, Mouridsen H, Kroman N, Prognostic effect of estrogen receptor status across age in primary breast cancer, Int J Cancer, 2008, 122(5):1089-1094.
-
(2008)
Int J Cancer
, vol.122
, Issue.5
, pp. 1089-1094
-
-
Bentzon, N.1
Düring, M.2
Rasmussen, B.B.3
Mouridsen, H.4
Kroman, N.5
-
16
-
-
84899596715
-
Sequence of radiation therapy and chemotherapy as adjuvant treatment in breast cancer
-
Abu-Hamar Ael-H, Barakat AF, Elgantiry M, Nasef HH, Sequence of radiation therapy and chemotherapy as adjuvant treatment in breast cancer, J Egypt Natl Canc Inst, 2010, 22(1):95-104.
-
(2010)
J Egypt Natl Canc Inst
, vol.22
, Issue.1
, pp. 95-104
-
-
Abu-Hamar, A.-H.1
Barakat, A.F.2
Elgantiry, M.3
Nasef, H.H.4
-
17
-
-
70849122251
-
Triple-negative breast cancer-current status and future directions
-
Gluz O, Liedtke C, Gottschalk N, Pusztai L, Nitz U, Harbeck N, Triple-negative breast cancer-current status and future directions, Ann Oncol, 2009, 20(12):1913-1927.
-
(2009)
Ann Oncol
, vol.20
, Issue.12
, pp. 1913-1927
-
-
Gluz, O.1
Liedtke, C.2
Gottschalk, N.3
Pusztai, L.4
Nitz, U.5
Harbeck, N.6
-
18
-
-
80051484394
-
Triple-negative breast cancers: An updated review on treatment options
-
Reddy KB, Triple-negative breast cancers: an updated review on treatment options, Curr Oncol, 2011, 18(4):e173-e179.
-
(2011)
Curr Oncol
, vol.18
, Issue.4
-
-
Reddy, K.B.1
-
19
-
-
0033944252
-
Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancers
-
Molino A, Pavarana M, Micciolo R, Nortilli R, Pedersini R, Manno P, Bozzi P, Bonetti F, Piubello Q, Cetto GL, Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancers, Ann Oncol, 2000, 11(5):581-586.
-
(2000)
Ann Oncol
, vol.11
, Issue.5
, pp. 581-586
-
-
Molino, A.1
Pavarana, M.2
Micciolo, R.3
Nortilli, R.4
Pedersini, R.5
Manno, P.6
Bozzi, P.7
Bonetti, F.8
Piubello, Q.9
Cetto, G.L.10
-
20
-
-
0028150831
-
Natural history of small breast cancers
-
Karnofsky Memorial Lecture
-
Hellman S, Karnofsky Memorial Lecture. Natural history of small breast cancers, J Clin Oncol, 1994, 12(10):2229-2234.
-
(1994)
J Clin Oncol
, vol.12
, Issue.10
, pp. 2229-2234
-
-
Hellman, S.1
-
21
-
-
0022366152
-
Comparative study of the histopathology of breast cancer in a screened and unscreened population investigated by mammography
-
Gibbs NM, Comparative study of the histopathology of breast cancer in a screened and unscreened population investigated by mammography, Histopathology, 1985, 9(12):1307-1318.
-
(1985)
Histopathology
, vol.9
, Issue.12
, pp. 1307-1318
-
-
Gibbs, N.M.1
-
22
-
-
0028873366
-
Pathological and biological features of mammographically detected invasive breast carcinomas
-
Rajakariar R, Walker RA, Pathological and biological features of mammographically detected invasive breast carcinomas, Br J Cancer, 1995, 71(1):150-154.
-
(1995)
Br J Cancer
, vol.71
, Issue.1
, pp. 150-154
-
-
Rajakariar, R.1
Walker, R.A.2
-
23
-
-
0027202556
-
c-erbB-2 oncoprotein in screen-detected breast carcinoma: An immunohistological study
-
Soomro S, Taylor P, Shepard HM, Feldmann M, Sinnett HD, Shousha S, c-erbB-2 oncoprotein in screen-detected breast carcinoma: an immunohistological study, Int J Cancer, 1993, 55(1):63-65.
-
(1993)
Int J Cancer
, vol.55
, Issue.1
, pp. 63-65
-
-
Soomro, S.1
Taylor, P.2
Shepard, H.M.3
Feldmann, M.4
Sinnett, H.D.5
Shousha, S.6
-
24
-
-
0030780320
-
Biologic characteristics of breast cancer detected by mammography and by palpation in a screening program: A pilot study
-
Tweedie E, Tonkin K, Kerkvliet N, Doig GS, Sparrow RK, O'Malley FP, Biologic characteristics of breast cancer detected by mammography and by palpation in a screening program: a pilot study, Clin Invest Med, 1997, 20(5):300-307.
-
(1997)
Clin Invest Med
, vol.20
, Issue.5
, pp. 300-307
-
-
Tweedie, E.1
Tonkin, K.2
Kerkvliet, N.3
Doig, G.S.4
Sparrow, R.K.5
O'Malley, F.P.6
-
25
-
-
0031395460
-
Screening status in relation to biological and chronological characteristics of breast cancers: A cross sectional survey
-
Alexander FE, Anderson TJ, Hubbard AL, Screening status in relation to biological and chronological characteristics of breast cancers: a cross sectional survey, J Med Screen, 1997, 4(3):152-157.
-
(1997)
J Med Screen
, vol.4
, Issue.3
, pp. 152-157
-
-
Alexander, F.E.1
Anderson, T.J.2
Hubbard, A.L.3
-
26
-
-
0032407416
-
Mammographic densities and breast cancer risk
-
Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ, Mammographic densities and breast cancer risk, Cancer Epidemiol Biomarkers Prev, 1998, 7(12):1133-1144.
-
(1998)
Cancer Epidemiol Biomarkers Prev
, vol.7
, Issue.12
, pp. 1133-1144
-
-
Boyd, N.F.1
Lockwood, G.A.2
Byng, J.W.3
Tritchler, D.L.4
Yaffe, M.J.5
-
27
-
-
0037245313
-
Postmenopausal hormone therapy and change in mammographic density
-
Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G, Postmenopausal hormone therapy and change in mammographic density, J Natl Cancer Inst, 2003, 95(1):30-37.
-
(2003)
J Natl Cancer Inst
, vol.95
, Issue.1
, pp. 30-37
-
-
Greendale, G.A.1
Reboussin, B.A.2
Slone, S.3
Wasilauskas, C.4
Pike, M.C.5
Ursin, G.6
-
28
-
-
2342571082
-
Tamoxifen and breast density in women at increased risk of breast cancer
-
Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW, Tamoxifen and breast density in women at increased risk of breast cancer, J Natl Cancer Inst, 2004, 96(8):621-628.
-
(2004)
J Natl Cancer Inst
, vol.96
, Issue.8
, pp. 621-628
-
-
Cuzick, J.1
Warwick, J.2
Pinney, E.3
Warren, R.M.4
Duffy, S.W.5
-
29
-
-
11144242922
-
Mammographic density and estrogen receptor status of breast cancer
-
Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K, Mammographic density and estrogen receptor status of breast cancer, Cancer Epidemiol Biomarkers Prev, 2004, 13(12):2090-2095.
-
(2004)
Cancer Epidemiol Biomarkers Prev
, vol.13
, Issue.12
, pp. 2090-2095
-
-
Ziv, E.1
Tice, J.2
Smith-Bindman, R.3
Shepherd, J.4
Cummings, S.5
Kerlikowske, K.6
-
30
-
-
33748556244
-
Correlation of HER-2/neu over-expression with mammography and age distribution in primary breast carcinomas
-
Seo BK, Pisano ED, Kuzimak CM, Koomen M, Pavic D, Lee Y, Cole EB, Lee J, Correlation of HER-2/neu over-expression with mammography and age distribution in primary breast carcinomas, Acad Radiol, 2006, 13(10): 1211-1218.
-
(2006)
Acad Radiol
, vol.13
, Issue.10
, pp. 1211-1218
-
-
Seo, B.K.1
Pisano, E.D.2
Kuzimak, C.M.3
Koomen, M.4
Pavic, D.5
Lee, Y.6
Cole, E.B.7
Lee, J.8
-
31
-
-
39549101230
-
Estrogen receptor-negative invasive breast cancer: Imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression
-
Wang Y, Ikeda DM, Narasimhan B, Longacre TA, Bleicher RJ, Pal S, Jackman RJ, Jeffrey SS, Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression, Radiology, 2008, 246(2): 367-375.
-
(2008)
Radiology
, vol.246
, Issue.2
, pp. 367-375
-
-
Wang, Y.1
Ikeda, D.M.2
Narasimhan, B.3
Longacre, T.A.4
Bleicher, R.J.5
Pal, S.6
Jackman, R.J.7
Jeffrey, S.S.8
|